Cargando…

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus

Detalles Bibliográficos
Autores principales:	Mayr, LM, Powell, RL, Ngai, JN, Nádas, A, Nyambi, PN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442042/ http://dx.doi.org/10.1186/1742-4690-9-S2-P72

Ejemplares similares

Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus
por: Mayr, Luzia M., et al.
Publicado: (2012)

Intrasubtype C superinfected individuals mount delayed and low-titer autologous neutralizing antibody responses prior to superinfection
por: Basu, D, et al.
Publicado: (2012)

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
por: Powell, RL, et al.
Publicado: (2009)

HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
por: Basu, Debby, et al.
Publicado: (2012)

P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection
por: Nyambi, PN, et al.
Publicado: (2009)

P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
por: Gorny, MK, et al.
Publicado: (2009)

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape
por: Rong, R, et al.
Publicado: (2009)

P04-47. High-titer autologous and heterologous neutralizing antibody activity in acute SIV-infection
por: Schweighardt, B, et al.
Publicado: (2009)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
por: Archary, D, et al.
Publicado: (2012)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
por: Agyingi, L, et al.
Publicado: (2012)

Contrasting antibody responses to intrasubtype superinfection with CRF02_AG
por: Courtney, Colleen R., et al.
Publicado: (2017)

P03-07. Autologous neutralizing antibodies that select viral escape variants emerge late after SIV infection of rhesus monkeys
por: Yeh, WW, et al.
Publicado: (2009)

Comparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodies
por: Hermanus, T, et al.
Publicado: (2012)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

A novel fully human monoclonal antibody that neutralizes multiple human IFN-α subtypes effectively: a candidate therapy for SLE
por: Wang, Shuang, et al.
Publicado: (2015)

HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response
por: Cortez, Valerie, et al.
Publicado: (2012)

HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth
por: Sheward, Daniel J., et al.
Publicado: (2018)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda
por: Eller, L, et al.
Publicado: (2009)

P04-55 LB. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Pediatric lupus nephritis: impact of ethnicity on histological subtype and initial presentation
por: Jurencak, R, et al.
Publicado: (2008)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
por: Fouda, GG, et al.
Publicado: (2012)

P20-14. Co- and superinfection of partners in a cohort of couples previously infected by genotypically different viruses in Kigali
por: Manigart, O, et al.
Publicado: (2009)

A comprehensive binding and neutralization analysis of plasma of HIV-1 subtype-C infected donors from India suggest MPER directed neutralization
por: Andrabi, R, et al.
Publicado: (2012)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
por: Jacob, RA, et al.
Publicado: (2012)

Latent HIV-1 can be reactivated by superinfection in a Tat-dependent manner, which can lead to the emergence of recombinant viruses
por: Donahue, Daniel Aaron, et al.
Publicado: (2013)

Systemic administration of a broadly-neutralizing IgG antibody to generate HIV-neutralization responses in breast milk
por: Fouda, GG, et al.
Publicado: (2012)

Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
por: Lambert, Caroline A, et al.
Publicado: (2015)

Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy
por: Sneddon, SF, et al.
Publicado: (2010)

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

Neutralizing antibodies elicited in rabbits by patient-derived Env trimer immunization
por: Heyndrickx, L, et al.
Publicado: (2012)

Neutralization and enhancement of trans infection by erythrocyte-bound HIV with antibodies and complement
por: Beck, Z, et al.
Publicado: (2012)

Comparing diagnostic tests and biomarkers: trials in people with discordant test results
por: Hooper, Richard, et al.
Publicado: (2011)

The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization
por: Cincotta, CD Macedo, et al.
Publicado: (2012)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Construction and characterization of neutralizing antibody fragments for efficient access to V3 epitope
por: Maruta, Y
Publicado: (2012)

Mapping epitopes on CRF01_AE viruses recognized by broadly neutralizing antibodies in sera from elite neutralizers from North America and Thailand
por: O'Rourke, SM, et al.
Publicado: (2012)

Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1
por: Maroldo, L, et al.
Publicado: (2010)

Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus
por: Buchy, Philippe, et al.
Publicado: (2011)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f9iq4qenrj9jac5lqsnf44ecl2